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The antigenicity of lipids is still ill-defined, and there is very little evidence that
any pure lipid by itself will act as an antigen. To produce an immune response they
must be complexed with or coupled to carriers (1-6) . Only glycosphingolipids and
phosphatides have been found to function as haptens when mixed with carriers such
as serum albumin (7), methylated bovine serum albumin (8), or other auxillary lipids
(9-11), or when the glycolipid was incorporated into liposomes (12) . Antibodies to
glycolipids are usually directed primarily against the carbohydrate moiety (1, 7, 13,
14), and there is little evidence that antibodies can be formed to the free lipids even
though free fatty acids were reported to cause inflammatory delayed-type allergic skin
reactions (15, 16).
The purpose of this investigation was to synthesize and study the antigenicity and
immunological properties of a series of glycolipid antigens prepared by coupling
isomaltose oligosaccharides-varying in size from isomaltose to isomaltoheptaose-to
a lipid carrier, stearylamine, and to compare the antigenicities of the different stearyl-
isomaltosyl oligosaccharides thus obtained, either when injected alone or when
incorporated into liposomes. Isomaltoseoligosaccharides were chosen because they are
the predominant structural units of a1--),6 dextran (17). Antibodies raised to them
should cross-react with dextrans, and the heterogeneity of the response and the sizes
of their antibody combining sites could be studied by quantitative precipitin and
precipitin inhibition assays and could be compared with antidextran (18-22).
The stearyl-isomaltosyl oligosaccharides (stearyl-IM3 to IM7) when incorporated
into liposomes were agglutinated in the presence of specific antibodies and were lysed
ifcomplement was also present. When injected into rabbits they were antigenic, either
emulsified directly with complete Freund's adjuvant (CFA)l or incorporated into
* Aided by grants from the National Science Foundation (PCM 76-81029) and Cancer Center Support
grant CA 13696 to the Cancer Center, Columbia University.
f Portions of this work are from part I of a dissertation submitted by C. Wood in partial fulfillment of
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'Abbreviations used in this paper: BSA, bovine serum albumin; CFA, complete Freund's adjuvant; DNP-
Cap-PE, DNP-e-aminocaproylphosphatidyl-ethanolamine ; yglo, gammaglobulin; IM2, isomaltose
(DGlcal~6DGlc); IM3, isomaltotriose; IM4, isomaltotetraose; IM5, isomaltopentaose; IM6, isomaltohex-
aose; IM7, isomaltoheptaose; PBS, phosphate-buffered saline (0.01 M phosphate, 0.8 percent sodium
chloride, pH 7.2); SDS, sodium dodecyl sulfate; SRBC, sheep erythrocytes; TCA, trichloroacetic acid.
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liposomes plus CFA. The antisera obtained reacted with a1--3-6 dextrans and are
mainly IgG and IgM, as characterized by sodium dodecyl sulfate (SDS) gel electro-
phoresis. The purified antibodies examined by isoelectric focusing were seen to be
pauciclonal.
Materials and Methods
Chemicals.
￿
Stearylamine and dicetylphosphate were purchased from K and K Laboratories,
Inc., Plainview, N. Y. Sphingomyelin and cholesterol were obtained from Sigma Chemical Co.,
St. Louis, Mo. Sodium cyanoborohydride was purchased from Aldrich Chemical Co. Inc.,
Milwaukee, Wis. B512 dextran from Leuconostoc mesenteroides (N279 of 4 X 106-10 X 106 mol wt)
was obtained from Commercial Solvents Co., Terre Haute, Ind. (19, 23). Isomaltose (IM2),
isomaltotriose (IM3), isomaltotetraose (IM4), isomaltopentaose (IM5), isomaltohexaose (IM6),
and isomaltoheptaose (IM7) were described previously (24-27) .
Antisera.
￿
Rabbit anti-isomaltotrionic bovine serum albumin (BSA) and anti-isomaltohex-
aonic BSA conjugates that gave precipitin reactions with al-*6 dextrans were available (28,
29) .
Coupling of Isomaltose Ohgosacchandes to Stearylamine.
￿
The method was essentially that intro-
duced by Gray (30, 31) for coupling oligosaccharides to BSA using cyanoborohydride as the
reducing agent. Briefly, oligosaccharides and a fivefold molar excess ofstearylamine and sodium
cyanoborohydride were dissolved in a solvent consisting either of chloroform:ethanol:water or
tetrahydrofuran:water. The various oligosaccharides required a different ratio of organic and
aqueous solvents, as described in the text. The reaction mixture was kept at 37°C, and the
degree of completeness of the reaction wasjudged using paper and thin-layer chromatography
to follow the disappearance of free oligosaccharide.
Paper and Thin-layer Chromatography.
￿
Descending paper chromatography was carried out at
room temperature using Scheicher and Schuell paper, grade 589 Green Ribbon C (Scheicher
and Schuell, Inc., Keene, N. H.) . The solvent systems used (18) were: (a) butanol-pyridine-
water (6:4:3); (b) butanol-pyridine-water (35:39:26). Solvent a was used for smaller oligosac-
charides (IM2-IM4) and solvent b was used for larger oligosaccharides (IM5-IM7) . Ascending
thin-layer chromatography was also carried out at room temperature using Eastman Chroma-
togram sheet, 1381 silica gel (Eastman Kodak Co., Rochester, N. Y.) in solvent a or b. Sugars
were detected on paper and thin-layer chromatograms using alkaline silver nitrate (18) .
ChemicalAnalysis.
￿
Total hexose was determined by the orcinol, anthrone, and phenol sulfuric
acid methods (18) . Specific rotation was measured in a Perkin-Elmer 141 polarimeter (Perkin-
Elmer Corp., Norwalk, Conn.) using a 1 dm cell. Total N was measured by the ninhydrin
method (32).
Preparation of Liposomes.
￿
Liposomes were prepared by the method of Sessa and Weissmann
(33) with minor modifications and using the lipid ratio used by Yasuda et al. (34) with
sphinogmyelin:cholesterol :dicetylphosphate:antigen (2:1.5:0.2:0.1). Briefly, various lipids (20
g,mol total) were dissolved in chloroform in a 100-ml round bottom flask. The solution was
dried in a rotary evaporator to form a uniform thin film. 1 ml of 0.01 M phosphate-buffered
saline (PBS) at pH 7.2 or an isotonic solution of sodium dichromate was added, and the lipid
was dispersed on a vortex mixer; glass beads were added to help dispersion. Liposomes to be
used for injection were resuspended in PBS and those to be used for agglutination and
complement lysis were resuspended in the dichromate solution. The turbid suspension was
allowed to stand for 2 h at room temperature and then kept on ice while being sonicated for 3
min with an MSE (Measuring and Scientific Equipment Ltd., London, England) probe type
sonicator at an amplitude of 8,um. Liposomes suspended in PBS were used immediately for
immunization. Liposomes suspended in dichromate solution were passed through a Sepharose
6B column (25 cm X 1 cm) to separate liposomes with trapped dichromate from the excess
untrapped dichromate. After separation the liposomes were used immediately.
Agglutination of Liposomes.
￿
Liposomes incorporated with antigens were tested for agglutina-
tion by specific antisera in two ways: (a) by direct observation of aggregation under the
microscope. Antiserum was diluted with a Takatsy microtitrator (Cooke Engineering Co.,
Alexandria, Va.) in a microtiter plate, 25 ,ul of liposome suspensions was added to each well,434
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and the agglutination titer was scored as the highest dilution of the antiserum that gave
aggregation of liposomes as observed microscopically; (b) agglutination of liposomes was
followed spectrophotometrically by the change in absorbance at 600 rim, recording the increase
in absorption as the liposomes were agglutinated by antibodies (35) .
Lysis of Liposomes by Complement.
￿
Liposomes with trapped dichromate were used; in the
presence of specific antisera and complement, liposomes are lysed and release the dichromate
(36) . The experiment was carried out at 37°C in Lucite microdialysis chambers (37) using
membranes made from dialysis tubing. One side of the chamber was filled with liposome
suspension (125,u1) and the other with 125 ltl veronal buffer at pH 7.2 (18) . In the presence of
complement and antibody, liposomes are lysed, and released dichromate diffuses through the
membrane into thechamber with veronal buffer. By measuringtheamount ofdye in the buffer
chamber at equilibrium (absorption at 360 nm), percent lysis could be determined. Liposomes
treated with 1% Triton X were used to establish 100% lysis. Equilibrium was reached after 72
h of continuous rocking at 37°C.
Passive Hemagglutination.
￿
Sheep erythrocytes (SRBC) were coated with dextran according to
the method ofGhanta et al. (38) usingpartially periodateoxidized dextran B512 (39) . Briefly,
100 ltl of a 10 mg/ml solution of oxidized B512 was added to 1 ml of 10% SRBC in borate
buffer at pH 7.2. The cellswere stirred for 5 h at 37°C and then washed three times with PBS
and resuspended in PBS to be used for hemagglutination. Hemagglutination assays were
carried out using a Takatsy microtitrator with 0.025-ml loops and a 2% suspension of B512-
sheep erythrocytes (B512-SRBC).
Immunization Schedule.
￿
New Zealand whitefemale rabbits were used. After preimmunization
bleedings (designated by subscript x), rabbits were immunized; 0.5 /mol of the stearyl-
isomaltosyl oligosaccharide was used for each injection. The antigen was either suspended in
0.5 ml of saline or was incorporated in 0.5 ml of liposomes (20Jumol oftotal lipid). The antigens
were emulsified in 0.5 ml of CFA (Difco Laboratories, Detroit, Mich.) immediately before use;
0.25 ml was injected into each of the four footpads weekly for 3 wk. A blood sample was taken
on the 7th d after the last injection and tested for antidextran with B512-SRBC. If the titer
remained low, another set of injections was given; if the titer was high, the rabbit was bled
three times a week, 50 ml of bloodbeing taken each time, and the three bleedings were pooled.
0.25% phenol and 0.01% merthiolate were added, and the serum was stored at 4°C. Therabbit
wasallowed to rest for 1 wk, and a second set of three bleedings was taken; blood samples were
drawn as above until the titer dropped. As many as five courses totaling 15 injections were
given (Table IV).
Purification of Antidextran.
￿
A small amount of antibody was purified for gel analysis using
enzymaticdigestion of dextran-antidextran precipitates (40) . Approximately 10 ,ugof antibody
N was precipitated by B512 dextran as for a quantitative precipitin assay; the precipitate was
left at 4°C for 1 wk and washed five times with 1-ml portions of chilled saline. The washed
precipitate was then digested with dextranase (Sigma Chemical Co., EC 3.2.1.11 (411) at a
ratio of 1:5,000 (enzyme:dextran) . Theprecipitate was digested overnight at room temperature
and enzyme inactivated at 56°C for 1 h (42). The samples were used immediately for gel
analysis.
SDS-Polyacrylamide Gel Electrophoresis.
￿
SDS-polyacrylamide gelelectrophoresiswasperformed
in the Bio-Rad slab gel apparatus (Bio-Rad Laboratories, Richmond, Calif.) using the Maizel
gel system (43), at pH 7.2. A stacking gel of 3.5% acrylamide placed on top of a separating gel
of5% acrylamide wasused. Protein markerswere obtained from various sources. Purified rabbit
IgG was kindly provided by Dr. B. Pernis, Columbia University, New York; rabbit IgA was
provided by Dr. K. L. Knight ofthe University ofIllinois, Chicago, Ill .; albumin wasobtained
from Sigma Chemical Co., and gammaglobulin (yglo) was obtained from Miles Biochemicals,
Elkhart, Ind.
Isoelectric Focusing Gel.
￿
Analytical isoelectric focusing was carried out using the LKB 2117
multiphor unit. The gel was set in a thin layer of 5% polyacrylamide containing 2% ampholyte
(ampholines pH 3.5-10) according to the procedures given by the manufacturer (LKB-
Productor AB, Sweden). After focusing, usually 3 h after the maximum voltage (800 V) was
reached, the gel was removed and fixed with 12% trichloroacetic acid (TCA) overnight using
several changes. It was then soaked in methanol-acetic acid-H20 (25:7:68) for 2 h beforeCHARLES WOOD AND ELVIN A. KABAT
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staining into 0.25% Coomassie Blue in methanol-acetic acid-H20 (45:9:46) for 30 min.
Destaining was done with methanol-acetic acid-H20 (50:7:43) and subsequently with several
changes of methanol-acetic acid-H20 (25:7:68) .
Scanning of Gels.
￿
Gels stained with Coomassie Blue were scanned in a Gilford 2400S
spectrophotometer (Gilford Instrument Laboratories, Inc., Oberlin, Ohio) at Ate. Xerox copies
of the original scans were made, and the peaks were cut out and weighed to obtain the ratioof
the area under the peaks.
Results
Preparation of Stearyl-Isomaltohexaose. 97 mg of IM6 and a fivefold molar excess of
stearylamine (121 mg) and sodium cyanoborohydride (30 mg) were dissolved in 20
ml of tetrahydrofuran:water (30:12). The reaction mixture was kept at 37°C for 3 wk,
at which time most of the free IM6 had disappeared as judged by paper and thin-
layer chromatography. The reaction (30) illustrated with IM2 is shown in Fig. 1. The
solution was then taken to dryness in vacuo and extracted with chloroform and with
water (Fig. 2). The chloroform-soluble material (38.6 mg) consisted mainly of un-
reacted stearylamine; the water-soluble material (32.1 mg) contained uncoupled IM6
and excess cyanoborohydride. The stearyl-IM6 (127 mg) remained insoluble in both
chloroform and water and was dissolved in tetrahydrofuran (THF) -water (36:10) and
Reaction mixture
n
NH,CH,
CHO
CH,
OH
H,NH CH2MMwJwCH,
￿
H S r--BC N-
￿
'> lc(e' .
￿
;H=NH*CH2 NWWS/v CH,
Fta. 1.
￿
Proposed mechanism (30) for coupling isomaltose oligosaccharides to stearylamine using
sodium cyanoborohydride.
Dried in vacuo
Extract 3X with CHC13
CHC13 insoluble
￿
CHC13soluble
Extract 3X with H2O
H2Osoluble
￿
H2O and CHC13 insoluble
y
Column chromatography
LH-60
FiG. 2.
￿
Schematic diagram for purification of various stearyl-isomaltosyl oligosaccharides.436
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￿
Chromatography on an LH-60 (80 x 2.5 cm) column of (A) 64 mg of CHC13 and H2O
insoluble fraction of the stearyl-IM6 reaction mixture, and (B) purified stearyl-IM6 .
passed through an LH-60 column (Pharmacia Fine Chemicals, Div. of Pharmacia
Inc ., Piscataway, N . J .) . The elution pattern is shown in Fig. 3A ; stearylamine was
determined by ninhydrin assay for total N after digestion with H2SO4 (32) and sugar
was determined by optical rotation at 365 nm . Stearyl-IM6 was detected both by N
and optical rotation ; it eluted with a peak at approximately tube 120 ; compounds
with a higher lipid:sugar ratio and free lipids were eluted at approximately tube 130 .CHARLES WOOD AND ELVIN A. KABAT
Because the two peaks were not completely separated, the fractions containing stearyl-
IM6 were pooled and passed through the column several more times to get rid of
contaminating free lipid. The purified compound came out as a single peak (Fig. 3B),
and the central portion of the peak was pooled and dried in vacuo to yield 29 mg of
final product. Paper chromatography in solvent B for 36 h showed a single spot
migrating more slowly than IM6 (RIM6 = 0.73). Analysis for hexose gave 61 and 63%
by the orcinol and phenol sulfuric acid methods, and theory gave 65%; total N was
1 .0%, and theory, 1 .10%; and specific optical rotation in THF-H20, +97° at 589 nm
and 20°C. The other stearyl-isomaltosyl oligosaccharide conjugates were purified in
a similar manner, except that different solvents were used. Approximately 100 mg of
IM2, IM3, IM4, IM5, and IM7 were used, and the final coupled products that were
isolated weighed 89, 72, 37, 26, and 20 mg, respectively. Analytical data are summa-
rized in Table I.
* THF gave a very high background with anthrone.
TABLE I
Characterization of Various Stearyl-Isomaltosyl Oligosaccharides
Total N
￿
Hexose
Solvent for col-
TABLE II
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Agglutination (Read Microscopically) by Rabbit Antisera to Isomaltosyl Oligosaccharides Coupled to BSA
of Liposomes Containing Stearyl Isomaltose Oligosaccharides
* Titerexpressed as reciprocal ofthe highest dilution ofserum that gave aggregation as read microscopically.
Compound
Molecular
weight
umn chromatog-
raphy
[ .JD
degrees
Experimen-
tal
'70
Theory
Orcinol
Experimental
Phenol
sulfuric
to
An-
throne
Theory
"70
CHCI3:ETOH:
Hz0
Stearyl-IM2 573 5:5:1 +38 2.2 2.4 29 28 27 28
CHCIs:ETOH:
H,O
Stearyl-IM3 735 3.5:5:1 +68 1 .8 1.8 43 49 45 45
CHC1s:ETOH:
H2O
Stearyl-IM4 897 2.4:41 +90 1 .6 1.5 49 55 53 54
THF:H20
Stearyl-IM5 1059 36:10 +68 1.3 1.2 58 60 ' 61
THF:H2O
Stearyl-IM6 1221 36:10 +97 1 .1 1.1 61 63 " 65
THFHaO
Stearyl-IM7 1383 23:11 +111 0.8 l.0 71 67 ' 69
R-25 anti-
IM3-BSA
R-25x
(preimune
m5x
serum)
R-28 anti-
IM3-BSA
R8x
(pre'
mune
serum)
R-49 anti-
IM6-BSA
(preim-
mune se-
rum)
IM2-liposomes 2* <2 2 <2 2 <2
IM3-liposomes 8 <2 128 2 128 <2
IM4-liposomes 16 <2 256 2 128 2
IM5-liposomes 16 <2 128 2 256 2
IM6-liposomes 16 <2 128 2 256 2
IM7-liposomes 16 <2 128 <2 128 2
Control liposomes <2 <2 <2 <2 <2 <2438
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Agglutination of Liposomes by Antisera .
￿
Stearyl-isomaltose oligosaccharides should be
readily incorporated into liposomes with the lipid portion embedded in the lipid
bilayer and the oligosaccharide moiety extending outward from the surface of the
liposomes, and they would be expected to be agglutinated by specific antiserum to
the isomaltose oligosaccharide if the oligosaccharide moiety projected sufficiently
from the liposome surface . Table II shows the titer, as observed microscopically, of
anti-isomaltotrionic BSA (R-25 and R-28 ; 28) and anti-isomaltohexaonic BSA con-
jugates (R-49 ; 29) in agglutinating various kinds of liposomes . IM2-liposomes were
only weakly agglutinated by all three sera, whereas IM3, IM4, IM5, IM6, and IM7
liposomes were agglutinated to similar titers . Of the three sera tested, R-25 was the
weakest and only gave a titer of 16 with various liposomes ; control preimmune sera
all gave background agglutination titers of <2 . The data suggest that stearyl-IM2
may not be protruding from the liposome surface sufficiently to react with the
antibody .
Aggregation of liposomes could also be detected by increased absorption of light
when specific antisera were added . Fig . 4 shows that stearyl-IM4 liposomes could be
agglutinated by R-25 (anti-isomaltotrionic BSA conjugates) at a dilution of 1 :8,
measuring the agglutination by the increased ODsoo . Control preimmune serum and
control liposomes without stearyl-isomaltosyl oligosaccharides did not show any
change in absorption .
Lysis ofLiposomes by Complement .
￿
Liposomes containing stearyl-isomaltose oligosac-
charides could also be lysed by complement in the presence of specific antibodies
(Table III) . 60% of the stearyl-IM4 liposomes were lysed after incubating at 37 °C for
72 h with complement and R-25 antiserum . Lysis was not recorded until 72 h to
allow released dichromate to equilibrate between the chambers of the equilibrium
dialysis cell . Stearyl-IM4 liposomes alone gave 31% spontaneous lysis after 72 h ;
controls ofcomplement alone or preimmune serum gave background lysis of 24 and
32%, respectively . Liposomes that did not contain stearyl-isomaltose oligosaccharides
showed no increase in lysis 72 h after adding antibody and complement . This
experiment was repeated with liposomes containing other stearyl-isomaltosyl oligosac-
charides ; IM3, IM5, IM6, and IM7 liposomes all showed lysis but IM2-liposomes did
not (data not shown), which was in agreement with the findings by agglutination,
0.7
TIME (min)
FIG . 4.
￿
Agglutination of liposomes as measured by OD ro0 . A, stearyl-IM4 liposomes plus R-25
(anti-isomaltotrionic-BSA ; 1:8) ; A, stearyl-IM4 liposomes plus R-25x (preimmune serum ; undi-
luted) ; ", control liposomes plus R-25 (1 :8) ; O, control liposomes plus R-25x (undiluted) .CHARLES WOOD AND ELVIN A. KABAT
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TABLE III
Lysis of Stearyl-IM4 Liposomes by Complement and Specific Antisera to Isomaltosyl
Oligosaccharides Coupled to BSA
* Measured by dialyzable dichromate liberated on equilibrium dialysis after 72 h at 37°C. Total
volume was 200 ttl. Liposomes treated with 1% Triton X were used to establish 100% lysis.
$ Undiluted serum was used.
indicating that stearyl-IM2 does not protrude from the liposome surface sufficiently
to react with antibody.
Antigenicity of Stearyl-Isomaltosyl Oligosaccharides.
￿
Stearyl-IM5 and stearyl-IM6 were
antigenic in rabbits when incorporated into liposomes and mixed with CFA. However,
they were also antigenic when emulsified in CFA without liposomes (Table IV) .
Antibodies formed against stearyl-isomaltosyl oligosaccharides cross-react with a 1--~'6
dextrans, and the antibody level could be followed by hemagglutination of B512
dextran-coated SRBC. A few rabbits showed a high preimmune titer against B512-
SRBC, even though precipitation with B512 was not measurable. Rabbits immunized
by intravenous injection of stearyl-IM5 and stearyl-IM6 with or without liposomes in
the absence of CFA generally did not respond; however, two rabbits (R-853 and R-
865) showed a fourfold increase in titer, but the sera did not precipitate with dextran.
Rabbits immunized with antigen in CFA responded after 3-6 injections, whereas
those immunized without CFA did not respond, even after 15 injections, thus showing
that CFA is important in enhancing the antigenicity of stearyl-isomaltosyl oligosac-
charides.
Rabbit antisera to other stearyl-isomaltosyl oligosaccharides were also obtained by
immunization with stearyl-IM2, -IM3, -IM4, and -IM7 in liposomes plus CFA. Their
responses are summarized in Table IV. All rabbits injected with stearyl-IM4 and
stearyl-IM7 gave good titers, whereas only two of three responded to stearyl-IM3 and
only one of four mounted a weak response to stearyl-IM2.
Agglutination and Lysis of Liposomes by Antisera to Stearyl-Isomaltosyl Oligosaccha-
rides. Table V gives the results of liposome agglutination assays on the various
antisera to stearyl-isomaltosyl oligosaccharides. Liposomes containing stearyl-IM3,
-IM4, -IM5, -IM6, and -IM7 were agglutinated as observed microscopically, whereas
liposomes with stearyl-IM2 were only weakly agglutinated; these findings are com-
parable to those using anti-isomaltotrionic BSA and anti-isomaltohexaonic BSA
conjugates antisera (Table II). Agglutination was accompanied by an increase of
ODsoo similar to Fig. 4. Lysis of liposomes was also seen with R-663 serum and
Liposomes Serum
Guinea pig
complement Lysis*
125 ttl 25 ttl %
Stearyl-IM4 liposomes R-25 anti-IM3 BSA$ 25 ttl 60
Stearyl-IM4 liposomes R-25 anti-IM3 BSA - 29
Stearyl-IM4 liposomes R-25x preimmune serum$ 25 ttl 32
Stearyl-IM4 liposomes - - 24
Stearyl-IM4 liposomes - 25 ul 24
Control liposomes R-25 anti-IM3 BSA 25 Al 20
Control liposomes R-25 anti-IM3 BSA - 21
Control liposomes R-25x preimmune serum 25 Al 32
Control liposomes - - 30
Control liposomes - 25 ttl 21440
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TABLE IV
Responses ofRabbits to Stearyl-Isomaltosyl Oligosaccharides
All injections with CFA were intramuscular. Titers were determined by hemagglutination ofB512-SRBC.
* Time when larger bleedings were started; small test bleedings were made earlier.
Intravenous.
TABLE V
Agglutination of Liposomes (Read Microscopically) by Rabbit Antisera to Stearyl-Isomaltosyl
Oligosaccharides
* All other rabbits injected with stearyl-IM2 did not agglutinate any of the liposomes listed.
Immunogen
Rabbit
number
Antigen
per in-
jection
Preim-
mune
titer
Titer after
three in-
jections
Titer after six
injections
Titer after
fifteen in-
jections
mg
Stearyl-IM2 liposomes + CFA R843 0.7 8 8 16 16
8854 0.7 16 32 64 64
R855 0.7 64 128 256 256*
R864 0.7 16 16 16 16
Stearyl-IM3 liposomes + CFA R841 0.6 64 64 128 128
R839 0.6 256 256 256 1,000*
R859 0.6 32 32 512*
Stearyl-IM4 liposomes + CFA R663 0.5 32 1,000*
R664 0.5 64 128 1,000*
Stearyl-IM5 liposomes + CFA R847 0.45 32 64 512 (died)
R848 0.45 128 256 1,000*
R856 0.45 8 16 512*
Stearyl-IM6 liposomes + CFA R842 0.4 128 256 1,000*
R846 0.4 32 32 512*
Stearyl-IM7 liposomes + CFA R849 0.4 16 32 512*
R850 0.4 128 1,000*
Stearyl-IM5 + CFA R860 0.45 128 512 2,000*
R861 0.45 4 128 1,000*
Stearyl-IM5 liposomes$ R864 0.45 32 64 64 64
R865 0.45 16 32 64 64
Stearyl-IM5$ R866 0.45 4 8 8 8
R868 0.45 8 16 8 8
Stearyl-IM6 + CFA R851 0.4 64 512*
R862 0.4 4 128 2,000*
Stearyl-IM6 liposomes$ R852 0.4 16 32 64 64
R853 0.4 64 64 64 64
Stearyl-IM6$ R857 0.4 8 8 8 8
R858 0.4 16 32 32 32
R-663 anti-
stearyl-IM4
liposomes
R663x
(preimmune
serum)
R-856 anti-
stearyl-IM5
liposomes
R-856x
R855 anti-
stearyl-IM2
liposomes*
R-855x
IM2-liposomes 2 <2 2 <2 2 <2
IM3-liposomes 8 <2 8 <2 4 <2
IM4-liposomes 16 <2 16 <2 8 <2
IM5-liposomes 16 <2 32 <2 8 <2
IM6-liposomes 16 <2 32 <2 16 <2
IM7-liposomes 16 <2 32 <2 16 <2
Control liposomes <2 <2 <2 <2 <2 <2CHARLES WOOD AND ELVIN A. KABAT
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TABLE VI
Lysis ofStearyl-IM4 Liposomes by Anti-Stearyl-Isomaltosyl Oligosaccharides and Complement
Lysis*
Guinea R-663 R-856 R-855
* Measurement by dialyzable dichromate liberated on equilibrium dialysis after 72 h at 37 °C. Total
volume was 2001e1 .
$Undiluted serum was used .
FIG . 5 .
￿
SDS-polyacrylamide gel electrophoresis ofvarious purified antibodies to stearyl-isomaltosyl
oligosaccharides and isomaltosyl oligosaccharide-BSA conjugates . Lane 1, rabbit yglo ; 2, crude
rabbit albumin; 3, MOPC104E (mouse IgM) ; 4, rabbit IgA; 5, purified rabbit IgG; 6, R-855 anti-
stearyl-IM2 liposomes, CFA; 7, R-839 anti-stearyl-IM3 liposomes, CFA; 8, R-859 anti-stearyl-IM3
liposomes, CFA; 9, R-663 anti-stearyl-IM4 liposomes, CFA; 10, R-664 anti-stearyl-IM4 liposomes,
CFA; 11, R-848 anti-stearyl-IM5 liposomes, CFA ; 12, R-856 anti-stearyl-IM5 liposomes, CFA; 13,
R-842 anti-stearyl-IM6 liposomes, CFA; 14, R-846 anti-stearyl-IM6 liposomes, CFA; 15, R-849
anti-stearyl-IM7 liposomes, CFA; 16, R-850 anti-stearyl-IM7 liposomes, CFA; 17, R-860 anti-
stearyl-IM5, CFA; 18, R-861 anti-stearyl-IM5, CFA; 19, R-851 anti-stearyl-IM6, CFA; 20, R-862
anti-stearyl-IM6, CFA; 21, R-25 anti-isomaltotrionic-BSA ; 22, R-27 anti-isomaltotrionic-BSA; 23,
R-48 anti-isomaltohexaonic-BSA; 24, R-49 anti-isomaltohexaonic-BSA .
complement (Table VI) ; highest lysis (48%) of stearyl-IM4 liposomes was obtained
only in the presence of R-663 antiserum and complement . All other controls only
gave background lysis .
SDS-Polyacrylamide GelElectrophoresis and Isoelectric Focusing .
￿
The isotypes of various
anti-stearyl-isomaltosyl oligosaccharide antibodies were studied by SDS-gel electro-
phoresis at pH 7.2 using rabbit IgG, IgA, yglo, albumin (contaminated with yglo),
Liposomes Serum pigcom-
plement
anti-
stearyl-
IM41ipo-
somes
anti-
stearyl-
IM5lipo-
somes
anti-
stearyl-
IM21ipo-
somes
1251x1 25 Id 111
Stearyl-IM4 liposomes Immune serum$ 25 48 74 40
Stearyl-IM4 liposomes Immune serum - 10 25 12
Stearyl-IM4 liposomes Preimmune serum$ 25 18 23 20
Stearyl-IM4 liposomes - - 8 25 15
Stearyl-IM4 liposomes - 25 11 23 18
Control liposomes Immune serum 25 25 24 22
Control liposomes Immune serum 25 15 15 18
Control liposomes Preimmune serum 25 29 15 20
Control liposomes - - 14 27 15
Control liposomes - 25 18 23 17442
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TABLE VII
Ratio of IgM to IgG in Various Antisera as Determinedfrom Scans of Gels Stained
with Coomassie Blue
Fie . 6 .
￿
Isoelectric focusing pattern of various purified antibodies to stearyl-isomaltosyl oligosac-
charides and isomaltosyl oligosaccharide-BSA conjugates. Lane 1, rabbit yglo; 2, R-855 ; 3, R-839 ;
4, R-859 ; 5, R-663 ; 6, R-664; 7, R-848 ; 8, R-856 ; 9, R-842; 10, R-846 ; 11, R-849; 12, R-850 ; 13, R-
860 ; 14, R-861 ; 15, R-851 ; 16, R-862 ; 17, R-25 anti-isomaltotrionic-BSA ; 18, R-27 anti-isomalto-
trionic-BSA ; 19, R-48 anti-isomaltohexaonic-BSA ; 20, R-49 anti-isomaltohexaonic-BSA .
and mouse IgM (MOPC 104E) as markers . The antibodies studied were purified by
precipitation with dextran (B512) and subsequent digestion with dextranase, as
described in Materials and Methods . The gel (Fig. 5) shows the predominant isotypes
in all sera to be IgM and IgG, with very little IgA . The other bands that migrate
faster than IgG may beH and L chain dimers or H-L chains because upon reduction
with mercaptoethanol most of these bands disappeared and only 1-t, y, and L chains
were seen . The ratio ofIgM to IgG in the different antisera was calculated from scans
of gels stained with Coomassie Blue (Table VII) . The amounts of IgM and IgG vary
from serum to serum, with R-859 containing predominantly IgM, and with R-851,
R-862, and R-860 containing mostly IgG .
The heterogeneity of the antidextran response was studied by isoelectric focusing in
a pH gradient of 3.5-10 (Fig . 6) . Control rabbit yglo shows substantial hetero-
geneity, whereas in most of the antisera restricted heterogeneity is evident from the
Rabbit
number
Antigen IgM:IgG
R-855 Stearyl-IM 2 liposomes + CFA 1 .4 :1.0
R-839 Stearyl-IM 3 liposomes + CFA 1 .0 :1.09
R-859 Stearyl-IM 3 liposomes + CFA 9 .4 :1.0
R-663 Stearyl-IM 4 liposomes + CFA 1 .0 :1.07
R-664 Stearyl-IM 4 liposomes + CFA 1 .0 :2 .7
R-848 Stearyl-IM 5 liposomes + CFA 1 .0 :1 .6
R-856 Stearyl-IM 5 liposomes + CFA 1 .4 :1 .0
R-842 Stearyl-IM 6 liposomes +CFA 1 .7 :1 .0
R-846 Stearyl-IM 6 liposomes + CFA 1 .0 :1 .4
R-849 Stearyl-IM 7 liposomes +CFA 1 .0:2 .2
R-850 Stearyl-IM 7 liposomes + CFA 1 .3 :1 .0
R-860 Stearyl-IM 5 + CFA 1:400
R-861 Stearyl-IM 5 + CFA 1.0:2 .1
R-851 Stearyl-IM 6 + CFA No detectable IgM
R-862 Stearyl-IM 6 + CFA No detectable IgMCHARLES WOOD AND ELVIN A. KABAT
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presence of some intense bands in the isoelectric focusing patterns ascribable to a few
predominant responding clones. R-862 was most restricted with only six major bands
focusing at about pH 6.5. R-846 showed two distinct groups of clones, with one
focusing at about pH 6.1 and the other at pH 7.7 . Another rabbit, R-859, showed
only a few faint bands at -pH 6.1, and the majority o£ the antibodies remained at
the origin, which is in agreement with the SDS-polyacrylamide gel findings (Fig. 5)
showing that this serum contains mainly IgM that stayed at the origin. For compar-
ison, rabbit antibodies to isomaltotrionic-BSA (R-25, R-27) and isomaltohexaonic-
BSA conjugates (R-48, R-49) were also studied by isoelectric focusing (Fig. 6). They
are similar to the antibodies to stearyl-isomaltose oligosaccharides in having some
predominant intense bands, however, most of the bands focused over a lower pH
range than those obtained by immunizing with the stearyl-isomaltosyl oligosaccha-
rides.
Discussion
The present findings show that stearylamine can be covalently attached to isomal-
tose oligosaccharides by reductive amination catalyzed by the cyanoborohydride
anion to produce model glycolipids that are antigenic in rabbits. The reaction involves
coupling ofthe aldehyde group at the reducing end to the amino group ofstearylamine
(30; Fig. 1) with the opening of the reducing sugar ring. However, as reported by
Gray (31), who used sodium cyanoborohydride to couple oligosaccharides to protein
and to aminoethyl polyacrylamide gels, the reaction proceeds at a very slow rate. In
oligosaccharides, excess side reactions lead to the formation of tertiary amines as well,
but this may be eliminated by using an excess of amino groups. Consequently, all
reactions were carried out with a fivefold molar excess of stearylamine. These
conditions are still not ideal because during the purification of the coupled products
some unidentified compounds with a much higher lipid :sugar ratio were seen.
Schwartz and Gray (45) and Wiegandt and Ziegler (46) also noted substantial
amounts of unidentified amines when sodium cyanoborohydride was used for reduc-
tive amination of lactose with ammonium acetate. Despite these drawbacks, reductive
amination proved an efficient way to synthesize a series of stearyl-isomaltosyl oligo-
saccharides.
Glycolipids are usually not antigenic. Antibodies to glycolipids may be produced
(47) by injecting animals with cell membranes or subcellular particles containing the
glycolipids (48, 49) ; by immunizing with glycolipids covalently linked to a polymer
carrier (50, 51) ; by immunizing with a micellar suspension of purified lipid and
heterologous protein carriers such as serum albumin (7, 52) ; and by injecting emulsions
of glycolipids and CFA without carrier protein (53, 54) . Liposomes have also been
reported to function as carriers for various haptens. Kinsky's laboratory (55-58)
showed enhancement of anti-DNP responses in guinea pigs immunized with DNP-E-
aminocaproylphosphatidyl-ethanolamine (DNP-Cap-PE) incorporated with lipo-
somes, and van Rooijen and van Nieuwmegen (59) found higher levels of antihuman
serum albumin in rabbits injected with human serum albumin entrapped in liposomes.
The purpose of this investigation was to evaluate the antigenicity of the stearyl-
isomaltosyl oligosaccharides as model glycolipids using liposomes as carriers and to
study the reactivities of the antibodies with various dextrans. Antibodies were titrated
easily by the agglutination of liposomes containing the antigen, or optically by444
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recording increased light absorption as liposomes are agglutinated by antibodies (3,
5) . A third method involves lysis of liposomes by complement and specific antibodies
using markers (36, 60, 61) to measure the degree of lysis. In our assay a colored
substance, sodium dichromate, was used as a marker, and the assay was carried out
in microequilibrium dialysis cells to minimize the quantities of liposomes, antibody,
and complement needed. Liposomes containing stearyl-IM2 were not agglutinated by
various antibodies to a1--)-6 dextran (Tables II and V), whereas those containing IM3
were agglutinated but weakly as compared to liposomes with IM4 to IM7 . This
indicates that with stearyl-IM2 the sugar moiety may not be protruding far enough
from the liposome surface to be recognized by antibodies ; at least two intact sugar
rings plus an a-linkage (stearyl-IM3) must extend from the liposomes before it can
bind antibodies. With the injection schedules used, stearyl-isomaltosyl oligosaccha-
rides alone or incorporated into liposomes without CFA did not induce a significant
antibody response (Table IV) . Antibodies cross-reacting with dextrans were obtained
when liposomes containing stearyl-isomaltosyl oligosaccharides were emulsified with
CFA. Moreover, stearyl-IM5 and -IM6 by themselves gave good antibody responses
when emulsified with CFA. Thus, with these glycolipids, liposomes are not required
as carriers ifCFA are used. Because glycolipids would be expected to form micelles in
CFA, the use of liposomes may be superfluous. Indeed, antibodies to other glycolipids
such as rat antigalatocerebroside (53) and rabbit anti-Forssman glycolipid (54) had
been raised using only an emulsion of the glycolipid and CFA. Dancey et al. (62) and
Honegger et al. (63) reported that when lipid A, a B cell mitogen, was incorporated
into liposomes with antigen, it enhanced the antibody response. Westphal et al. (64)
also reported that lysolecithin and other synthetic analogues can act as adjuvants. It
will be of interest to determine whether lipid A and other synthetic lysolecithin
analogues could substitute for CFA in enhancing the response to stearyl-isomaltosyl
oligosaccharides with or without liposomes.
The haptenic nature of glycolipid was first demonstrated by Landsteiner and
Simms (65), who showed that nonantigenic purified Forssman glycolipid could
become antigenic when complexed noncovalently with whole serum as a carrier or
"schlepper." It is now known that this carrier could be any heterologous protein, such
as serum albumin (7, 52) . The cellular basis of this is still poorly defined, and very
little is known about T cell dependency of responses to glycolipids. However, studies
of protein antigens such as BSA (66-68) coupled to fatty acids established a definite
need for T cells. Coon and Hunter (66), and subsequently Dailey and Hunter (67),
and Singh and Leskowitz (68) showed that coupling of dodecanoic acids to BSA
modified the immunogenicity of BSA leading to selective induction of delayed-type
hypersensitivity. In contrast to the above studies, coupling of haptens such as
fluorescein and DNP to phosphatidylethanolamine and incorporating them into
liposomes elicited humoral responses exclusively (69). Yasuda et al. (70) showed that
both nude and thymectomized mice mounted a significant anti-DNP response to
DNP-Cap-PE when incorporated into liposomes. Its thymus-independent character
was substantiated in that liposomes containing DNP-Cap-PE sustained a DNP-
specific response in cultures of primed spleen cells pretreated with antithymocyte
serum and complement (71) . However, it cannot be generalized that lipid-protein
conjugates, such as dodecanoic acid-BSA, require T cells and that lipid-hapten
conjugates, such as DNP-Cap-PE when incorporated on liposomes, are T independent,CHARLES WOOD AND ELVIN A . KABAT
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because another lipid-hapten conjugate, mono(azobenzenearsonic acid)-tyrosyl-phos-
phatidylethanolamine (ABA-tyr-PE), induced both humoral and cellular immunity
(57) . Therefore, T cell dependency may vary from one lipid antigen to another.
Because the role ofT cells in antibody formation to glycolipids is not clearly defined,
it would be of interest to study this with stearyl-isomaltosyl oligosaccharides with and
without the use of liposomes .
The dextran response in humans immunized with native or clinical dextrans (22)
was heterogeneous as evidenced by marked variations in relative binding affinity for
various isomaltose oligosaccharides, as were the antibodies cross-reacting with dextran
obtained by immunizing rabbits with isomaltosyl oligosaccharide-BSA conjugates
(28, 29) . In the latter instances this was perhaps due to the protein carrier being a
part of the antigenic determinant and the consequent formation of many antigenic
determinants . Most of the antibodies produced by stearyl-isomaltosyl oligosaccharides
with orwithout liposomes wereshown to be still somewhat heterogeneous, as evidenced
by the ability to fractionate these antisera into more restricted antibody fractions that
vary in the sizes of their antibody-combining sites2 and by isoelectric focusing.
However, a few antisera appeared to be considerably less heterogeneous. Restricted
anti-DNP and anti-phosphorylcholine responses were also elicited by DNP-Cap-PE
(56) and 3-[3-(4-azophenyl-phosphorylcholine)-4-hydroxyphenyl]-N-propionyl-phos-
phatidyl-ethanolamine (APPC-PPr-PE) (63) on liposomes . These antibodies also
showed restricted isoelectric focusing patterns and a narrow range of binding con-
stants, perhaps ascribable to the DNP or phosphorylcholine determinants being small,
thus maintaining a relatively defined conformation on the liposomes . With the
availability of this series of chemically defined glycolipids, by using inbred lines of
mice and guinea pigs, one can now attack problems of the genetic control of the
responses to glycolipids, their T cell dependency, and their ability to induce cellular
immunity, such as delayed-type hypersensitivity .
Summary
Isomaltose oligosaccharides varying in size from two sugars, isomaltose (IM2), to
seven sugars, isomaltoheptaose (IM7), were coupled to stearylamine by reductive
amination with sodium cyanoborohydride . Each compound was purified by column
chromatography to yield a series of glycolipids containing oligosaccharides differing
in length . Stearyl-isomaltotriose to stearyl-IM7 could be incorporated into liposomes
and could render them agglutinable by specific antibodies to al-->6 dextran and
could be lysed ifcomplement was also added, whereas those containing stearyl-IM2
were not agglutinated or lysed, indicating that stearyl-IM2 may not be protruding
from the liposome surface sufficiently to react with the antibody . Stearyl-isomaltosyl
oligosaccharides by themselves or incorporated into liposomes were equally antigenic
when emulsified in complete Freund's adjuvant . They elicited pauciclonal responses,
and the antibodies were al-*6 specific, cross-reacted with dextran, and gave semire-
stricted isoelectric focusing patterns .
2 Wood,C., and E . A . Kabat . Immunochemical studies on conjugates of isomaltosyl oligosaccharides to
lipid. III . Fractionation of rabbit antibodies to stearyl-isomaltosyl oligosaccharides and a study of their
combining sites by a competitive binding assay . Manuscript submitted for publication .446
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